FRANKLIN, Tenn., April 13, 2011 /PRNewswire/ — In the
Journalof Advanced Nursing March issue,
a comparative research evaluation of five needleless I.V.
connectors tested by an independent laboratory showed that the
RyMed InVision-Plus® (RYM-5001®) zero displacement
connector best protected the intraluminal pathway from bacteria
compared with four other commonly used connectors.
The purpose of the study was to evaluate in-vitro
differences of colony forming units (CFUs) of four different
bacteria (Staphylococcus epidermidis, Staphylococcus aureus,
Pseudomonas aeruginosa, Escherichia coli) over four days, using
bovine blood, in five needleless connectors (three negative
displacement, one positive pressure, and one zero
displacement).
“This is a wonderful validation of our product in the world’s
most read nursing journal focused on advancement of evidence-based
nursing,” said Dana Wm. Ryan, President & CEO, RyMed
Technologies, Inc. “The ultimate goal is to provide the best
patient safety no matter if you’re a nurse, infection control
specialist, family member or parent with a sick child. We
believe our product considerably outperformed the other connectors
tested in protecting against the potential for bloodstream
infections and occlusions as measured by the independent
study.”
According to the authors, Cynthia Chernecky, Ph. D., RN, FAAN,
and Jennifer Waller Ph. D., the data supports use of the least
harmful technologies to enhance the safety of intravenous care in
all settings and for all patients, although further comparative
independent research is needed. “Staff nurses, managers,
infection control specialists and vascular access specialists in
all settings need to use technologies that invoke the least patient
harm,” stated the article authors.
The Journal of Advanced Nursing (JAN) is an
international, peer-reviewed, scientific journal.
JAN
‘/>”/>
